Dr. Barbara Moscicki
Title and Affiliation
Professor of Pediatrics
Chief, Division of Adolescent and Young Adult Medicine
University of California, Los Angeles
Co-Chair, Adolescent and Young Adult Working Group
Dr. Barbara Moscicki, MD is a Pediatrician and is board certified in Adolescent Medicine but has also trained in STI epidemiology at UCSF, molecular virology at Stanford and mucosal immunology at the McFarland Burnette Institute and the Walter and Eliza Hall Institute in Melbourne. She has 33 years of experience working in the field of molecular epidemiology, behavioral studies of adolescents, mucosal immunology, and phase I and II clinical trials. Much of her work has focused on detailing the natural history of HPV in adolescents primarily from the 25-year study “Natural History of HPV in Teens” of which this application is a competitive continuation. She has also been involved in a phase I trial of vaginal microbicides and phase II HPV vaccine trials; the most recent is in 9-12 year olds determining if one dose is adequate for healthy children. She has carried her R37 work into the field of HIV where she has worked since 1993 starting with Adolescent HIV and AIDS Research Network (AMHARN), where she was chair of the Basic Science Group and later a site PI for the Adolescent Therapeutic Trial of which she oversaw more than 20 clinical protocols. She was also involved in IMPAACT on HPV vaccination in perinatally HIV infected children. Now, she has several protocols within Pediatric HIV/AIDS Cohort Study (PHACS) study including oral health study which examined the role of the oral microbiome and inflammatory cytokines in oral disease. Currently as part of PHACS, she leads the HPV substudy of AMP and AMP-Up to examine why PHIV children appear to have little to no efficacy from the HPV vaccine. Her research has crossed numerous disciplines including behavioral, epidemiology, social science, public health, virology and immunology.